Okuwaki Hajime, Kato Yoshiaki, Lin Lisheng, Nozaki Yoshihiro, Takahashi-Igari Miho, Horigome Hitoshi
Department of Child Health, Faculty of Medicine University of Tsukuba Tsukuba Japan.
Division of Pediatric Cardiology National Cerebral and Cardiovascular Center Suita Japan.
J Arrhythm. 2019 Jun 17;35(4):685-688. doi: 10.1002/joa3.12209. eCollection 2019 Aug.
For applying a genotype-based treatment in neonatal long QT syndrome (LQTS), early detection of the genotype becomes an important issue. We report a case of a neonate with LQTS type 3 that presented with 2:1 atrioventricular block and underwent a mexiletine infusion challenge test, and achieved shortening of the QTc and 1:1 atrioventricular conduction. The mexiletine infusion challenge test was helpful to make an early detection of the genotype of the LQTS and predicted the drug efficacy in a neonatal patient.
对于在新生儿长QT综合征(LQTS)中应用基于基因型的治疗,基因型的早期检测成为一个重要问题。我们报告了一例3型LQTS新生儿病例,该患儿表现为2:1房室传导阻滞,并接受了美西律输注激发试验,结果QTc缩短且房室传导转为1:1。美西律输注激发试验有助于早期检测LQTS的基因型,并预测新生儿患者的药物疗效。